Total planned funding: $889,832,614
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $176,154,295 |
Nigeria | $163,082,884 |
Tanzania | $122,514,415 |
Uganda | $98,656,248 |
Zambia | $73,027,981 |
Mozambique | $45,385,540 |
Côte d'Ivoire | $32,379,692 |
South Africa | $30,039,118 |
Rwanda | $27,172,742 |
Zimbabwe | $26,030,711 |
Ethiopia | $25,132,215 |
Haiti | $16,010,002 |
Vietnam | $13,888,275 |
Democratic Republic of the Congo | $10,745,355 |
Ukraine | $8,800,000 |
Botswana | $8,411,542 |
Eswatini | $6,348,711 |
Guyana | $2,192,864 |
South Sudan | $1,829,817 |
Namibia | $1,215,324 |
Malawi | $662,069 |
Cameroon | $69,354 |
Papua New Guinea | $57,440 |
Central Asia Region | $26,020 |
Organizational Types
Private Contractor | $544,707,542 |
Unknown | $122,035,759 |
Host Country Government Agency | $101,198,730 |
NGO | $53,309,677 |
University | $29,695,193 |
FBO | $29,219,774 |
Own Agency | $3,757,795 |
Implementing Agency | $3,522,995 |
Other USG Agency | $1,255,016 |
Parastatal | $1,130,133 |
Program Areas
Treatment | $889,832,614 |
Budget Codes
HTXD: Treatment: ARV Drugs | $889,832,614 |